Quarterly Cash Dividends, Stock Movements, Financial Results, and Product Recognitions - Analyst Notes on Cypress, Cavium, Vishay, Intersil and Mellanox
Editor Note: For more information about this release, please scroll to bottom.
NEW YORK, May 20, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding Cypress Semiconductor Corporation (NASDAQ: CY), Cavium, Inc. (NASDAQ: CAVM), Vishay Intertechnology Inc. (NYSE: VSH), Intersil Corporation (NASDAQ: ISIL) and Mellanox Technologies, Ltd. (NASDAQ: MLNX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2666-100free.
--
Cypress Semiconductor Corporation Analyst Notes
On May 12, 2014, Cypress Semiconductor Corporation (Cypress) declared that its Board of Directors approved a quarterly cash dividend of $0.11 per share. Holders of record of the Company's common stock at the close of business on June 26, 2014 will be paid dividends on July 17, 2014. The full analyst notes on Cypress are available to download free of charge at:
http://www.analystsreview.com/2666-CY-20May2014.pdf
--
Cavium, Inc. Analyst Notes
On May 15, 2014, Cavium, Inc.'s (Cavium) stock increased 0.36%, ending the day at $42.14. Over the previous five trading sessions, shares in Cavium gained 1.66% compared to the Nasdaq Composite which gained 0.44% during the same period. The full analyst notes on Cavium are available to download free of charge at:
http://www.analystsreview.com/2666-CAVM-20May2014.pdf
--
Vishay Intertechnology Inc. Analyst Notes
On May 6, 2014, Vishay Intertechnology Inc. (Vishay) reported its Q1 FY 2014 financial results (period ended March 29, 2014). Q1 FY 2014 net revenues were $602.4 million, up 8.7% YoY. Net earnings attributable to Vishay stockholders for Q1 FY 2014 were $25.8 million or $0.17 per diluted share, versus $28.9 million or $0.19 per diluted share in Q1 FY 2013. Q1 FY 2014 operating margin was 7.1% compared with 8.2% in Q1 FY 2013. Dr. Gerald Paul, President and CEO, commented, "The first quarter represented a promising start to 2014 for Vishay. We experienced continued economic improvement in almost all market segments and a positive outlook across the board. Point of sale, the sales of Vishay products by its distributors to end customers, increased 6% quarter over quarter while inventory turns of Vishay products at its distributors increased to 3.6." The full analyst notes on Vishay are available to download free of charge at:
http://www.analystsreview.com/2666-VSH-20May2014.pdf
--
Intersil Corporation Analyst Notes
On May 14, 2014, Intersil Corporation (Intersil) declared that its high-current buck-boost and boost switching regulator family, ISL911xx, was chosen as the 2014 American Business AwardsSM finalist in the New Product or Service of the Year, under the "Hardware - Semiconductor or Other Electronic Component" category. Intersil informed that the product family was given the finalist position due to its capability to lengthen battery life and enhance efficiency of mobile devices. Andrew Cowell, Senior Vice President of Mobile Power Products at Intersil, commented, "Intersil continues to extend its leadership in power management technology for battery-powered mobile devices and consumer electronics, and we're honored that the American Business Awards sees the value in our high-current buck-boost and boost switching regulator family." Cowell added, "This nomination underscores the fact that Intersil helps OEMs deliver the best end-user experience, improving the system performance and power efficiency of their devices." The full analyst notes on Intersil are available to download free of charge at:
http://www.analystsreview.com/2666-ISIL-20May2014.pdf
--
Mellanox Technologies, Ltd. Analyst Notes
On May 15, 2014, Mellanox Technologies, Ltd.'s (Mellanox) stock declined 0.85%, ending the day at $31.38. Over the past month, shares in Mellanox declined 14.26%, compared to the Nasdaq Composite which increased 0.87% during the same period. The full analyst notes on Mellanox are available to download free of charge at:
http://www.analystsreview.com/2666-MLNX-20May2014.pdf
--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article